Skip to content

Theraputic Effect and Central Mechanism of Acupuncture for Treating Postmenopausal Insomnia

Using large-scale network analysis to investigate the central mechanisms of acupuncture for treating postmenopausal insomnia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000045
Enrollment
Unknown
Registered
2025-01-08
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal Insomnia

Interventions

Sham acupuncture group:Sham acupuncture

Sponsors

Traditional Chinese Medicine Hospital of Meishan
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Female 45 = age = 60 = 6 years of education right-handed; 2) meeting the diagnostic criteria of STRAW+10 menstrual disorders or Final Menstrual Period (FMP) > > 1 year; 3)meeting the diagnostic criteria of ICSD-3 4) Pittsburgh Sleep Quality Index (PSQI) score = 7; 5) not taking medication for at least two weeks prior to entering the study and 6) voluntarily participating in this study and signing an informed consent form.

Exclusion criteria

Exclusion criteria: 1) those with a history of systemic diseases such as hypertension diabetes mellitus coronary artery disease etc.; 2) those with comorbidities of cardiovascular cerebrovascular hepatic renal and hematopoietic systems and other serious and life-threatening primary diseases; 3) those who are unconscious and are unable to express the subjective symptoms of discomfort; 4) those who have insomnia due to alcoholism and/or psychotropic substance abuse and dependence (including sleeping pills); 5) those who are accompanied by symptoms of severe depression and anxiety; and 6) those who are accompanied by severe headaches migraine history of head trauma and history of surgery; 7) history of anticoagulant use or routine use of sedatives or anxiolytics; 8) previous contraindications to magnetic resonance scanning e.g. claustrophobia metal implants tattoos etc.

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index;Insomnia Severity Index;

Secondary

MeasureTime frame
Wake after sleep onset;Sleep efficiency;the Self-Rating Anxiety Scale;the Self-Rating Depression Scale;Morningness-eveningness questionnaire;Non-rapid eye movement sleep: Including N1 N2 N3;Sleep latency;Total sleep time;Montreal cognitive assessment;Rapid eye movement period;

Countries

China

Contacts

Public ContactPan zhang

Traditional Chinese Medicine Hospital of Meishan

zp_ltcm@163.com18380446781

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026